Applied UV Inc. Announces Receipt of Provisional Patent for Our Pulse Modulated UVC LED System to be Added to Our Patented Fighter Flex LED Solution Expanding Significant Revenue Opportunity
29. Januar 2024 07:00 ET
|
Applied UV, Inc.
DENVER, CO, Jan. 29, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV Inc. (NASDAQ: AUVI), a leader in smart building technology solutions, announced the introduction of its industry...
Optimi Completes Proprietary Natural Psilocybin Extraction Process and Files U.S. Provisional Patent
01. August 2023 07:30 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), an end-to-end drug researcher and formulator...
AXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay Manufacturing
14. März 2023 09:00 ET
|
AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Announces Provisional Patent Filing on Proprietary Use of Materials for Ophthalmological Test Strip Manufacturing SAN DIEGO, CA, March 14, 2023 (GLOBE...
Medaro Provides Update on Technology Development and Field Exploration Programs
27. Juli 2022 08:00 ET
|
Medaro Mining Corp.
VANCOUVER, British Columbia, July 27, 2022 (GLOBE NEWSWIRE) -- Medaro Mining Corp. (CSE: MEDA) (OTC: MEDAF) (FWB: 1ZY) (“Medaro” or the “Company”), a multi-faceted venture aimed at developing...
Optimi Health Submits Natural Psilocybin Combined Drug Delivery and Extraction Formulations for Provisional Patent
18. Januar 2022 09:00 ET
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 18, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Tauriga Sciences, Inc. Converts its U.S. Provisional Patent Application (Filed on March 17, 2020) to a U.S. Non-Provisional Patent Application
22. März 2021 06:18 ET
|
Tauriga Sciences
To Enhance Its Existing Intellectual Property Portfolio, the Company Filed an Additional U.S. Provisional Patent Application Directed to: Alternative Pharmaceutical Cannabinoid Delivery Systems NEW...
Zomedica Files U.S. Provisional Patent Application for Novel Pharmaceutical Formulation
12. Juli 2016 07:45 ET
|
Zomedica
ANN ARBOR, Mich., July 12, 2016 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM), a veterinary pharmaceutical company, today announced that it has filed a provisional application for...